These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4229530)

  • 1. [Anti-lymphocyte serum, bone marrow and immunological tolerance in the young dog].
    Otte H; Grosjean O
    C R Seances Soc Biol Fil; 1967; 161(4):959-62. PubMed ID: 4229530
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R; Brendel W; Pichlmayr I
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):313-9. PubMed ID: 4969335
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral antibody in allograft reactions.
    Winn HJ
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological considerations of bone marrow transplantation.
    Uphoff DE
    Transplant Proc; 1969 Mar; 1(1):39-43. PubMed ID: 4944248
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of cytotoxicity of lymphocytes from tolerant donors by antibodies to target cell alloantigens.
    Bubeník J; Perlmann P; Hasek M
    Transplantation; 1970 Oct; 10(4):290-6. PubMed ID: 4251471
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts.
    Franco DJ; Monaco AP
    Surg Forum; 1968; 19():175-7. PubMed ID: 4887902
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tolerance to cardiac allografts by irradiation and bone marrow transplantation.
    Boyd AD; Spencer FC; Hirose H; Engelman RM; Cannon FD; Ferrebee JW; Rapaport FT
    Surg Forum; 1975; 26():304-5. PubMed ID: 766260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of anti-lymphocyte serum on the survival of the allogenic renal graft in the dog].
    Otte H; Grosjean O
    C R Seances Soc Biol Fil; 1967 Sep; 161(3):738-40. PubMed ID: 4229425
    [No Abstract]   [Full Text] [Related]  

  • 14. [Orthotopic homotransplantation of the liver in the dog: immunosuppressive treatment with anti-lymphocyte serum].
    Mikaeloff P; Pichlmayr R; Rassat JP; Messmer K; Bomel J; Tidow G; Etiennemartin M; Malluret J; Belleville P; Jouvenceau A; Falconnet J; Descotes J; Brendel W
    Presse Med (1893); 1967 Sep; 75(40):1967-70. PubMed ID: 4863092
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of allogeneic unresponsiveness in canine radiation chimerae, with particular reference to the possible existence of three closely linked genetic systems relevant to bone marrow transplantation.
    Rapaport FT; Ozaki A; Cannon FD; Mollen M; Blumenstock D; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1973 Mar; 5(1):845-52. PubMed ID: 4572147
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological enhancement as studied by cell culture techniques.
    Hellström KE; Hellström I
    Annu Rev Microbiol; 1970; 24():373-98. PubMed ID: 4927135
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum.
    Hasek M; Skamene E; Karakoz I; Chutná J; Nouza K; Bubeník J; Sovová V; Nĕmec M; Jonák J
    Folia Biol (Praha); 1968; 14(6):411-24. PubMed ID: 4236901
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary and renal transplantations in the dog treated by single and later repeated neonatal injections of bone marrow].
    Grosjean O; Bluemenstock D
    C R Seances Soc Biol Fil; 1967 Sep; 161(3):733-7. PubMed ID: 4229424
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of thymus in adoptive tolerance.
    Argyris BF
    J Immunol; 1968 Jun; 100(6):1255-8. PubMed ID: 4880143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.